Online: | |
Visits: | |
Stories: |
Global Infectious Disease Diagnostics Testing Market 2015-2019 is the latest addition to ReportsnReports.com industry research reports collection. The report is about 41 exhibits and 75 pages published in Oct-2015.
Infectious diseases are disorders caused by micro-organisms such as viruses, bacteria, fungi, and parasites. These diseases can be transmitted from one individual to another through either direct contact or indirect contact. Anti-infective drugs are used to kill (cidal) or stop the growth (static) of infectious agents. Based on the target organism, anti-infective drugs can be categorized into antibacterial, antiviral, antifungal, and antiparasitic. Anti-infective drugs can act via host defense system or can directly target the causative agent. Infectious diseases such as bacterial infections, respiratory diseases, HPV, and HIV are gradually increasing worldwide. For instance, based on the study of WHO global health observatory (GHO) data, it is estimated that in 2013 34-38 million people suffered from HIV infection worldwide. Infectious diseases increasingly threaten public health and contribute significantly to the rising costs of health care. Infectious disease diagnostic tests help in detecting new pathogens and specific pathogens, monitoring response to therapy, assessing prognosis, and determining appropriate treatment.
The forecast global infectious disease diagnostic testing market to grow at a CAGR of 11.48% over the period 2014-2019.
Covered in this report
The report covers the present scenario and growth prospects of the global infectious disease diagnostic testing market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of following product categories:
POC infectious disease diagnostics test is classified into the following based on application:
The report, Global Infectious Disease Diagnostic Testing Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers APAC, Europe, Latin America, MEA, and North America; it also covers the landscape of the global infectious disease diagnostic testing market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market
Purchase report directly @ http://www.reportsnreports.com/Purchase.aspx?name=429965
Single User License USD 2500
Key regions – Americas, APAC and EMEA
Key vendors – Abbott Diagnostic, Alere, bioMérieux, Diasorin, and Roche Diagnostic.
Other Prominent Vendors in the market are: Beckman Coulter, Becton, Dickinson and Company (BD), Bio-Rad Laboratories, Cavidi, Cepheid, Corgenix, Diaxonhit, Eiken Chemical, EMD Millipore, Epitope Diagnostic, EUROIMMUN, Gold Standard Diagnostics, Hologic, Immunetics, InBios International, J.Mitra, Meridian Bioscience, OraSure Technologies, ORGENTEC Diagnostika, Ortho Clinical Diagnostics, QIAGEN, Quidel, Siemens Healthcare Diagnostics, TECHLAB, Thermo Fisher Scientific, and Trinity Biotech.
Inquire for this report @ http://www.reportsnreports.com/contacts/InquiryBeforeBuy.aspx?name=429965
Single User License USD 2500
Key market driver
Key market challenge
Key market trend
Key Questions Answered in this Report
Contact [email protected] / Call +1 888 391 5441 for further information on “Global Infectious Disease Diagnostics Testing Market 2015-2019” report OR for any other market research and intelligence needs you may have for your business.